Illumina

Illumina, founded in 1998, stands at the forefront of genomics technology, driving innovation in sequencing and array-based solutions. With headquarters in San Diego, California, the company is committed to unlocking the power of the genome, enabling researchers and healthcare professionals to make breakthrough discoveries. With a workforce of approximately 9,300 employees, Illumina collaborates with scientists worldwide to push the boundaries of knowledge and improve human health.

The company's cutting-edge platforms and portfolio of products support a broad range of genomic applications, including cancer research, genetic disease studies, and agricultural advancements. Illumina aims to make genomics widely accessible and affordable, fostering a new era of personalised medicine where treatments are tailored to individual genetic profiles. Through robust partnerships and strategic alliances, Illumina continues to expand its influence, cementing its position as a leader in the biotechnology sector.

Under the leadership of CEO Jacob Thaysen, Illumina is dedicated to advancing genomic science and transforming the future of healthcare. The company's dynamic approach combines scientific expertise with a commitment to ethical practices and sustainability. Illumina's work is pivotal in addressing some of the most pressing global challenges, from disease prevention and treatment to food security and environmental conservation.